We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Stem Cells Used to Generate Functional Arterial Endothelial Cells

By LabMedica International staff writers
Posted on 20 Jul 2017
A team of cardiovascular disease researchers developed a method for using human pluripotent stem cells to generate fully functional arterial endothelial cells, which are vital for vascular development and disease research.

Currently, arterial endothelial cells that have been derived from human pluripotent stem cells have not been of clinical value as they have lacked the range of arterial-specific functions in vitro and the protective function for ischemic tissues in vivo.

To advance the production of functional arterial cells, investigators at the University of Wisconsin's Morgridge Institute for Research (Madison, USA) combined single-cell RNA sequencing and CRISPR-Cas9 technology to identify pathways for regulating arterial endothelial cell differentiation. More...
They then manipulated these pathways and generated arterial endothelial cells that demonstrated unprecedented arterial-specific functions as well as improved survival of myocardial infarction.

Single-cell RNA sequencing identified the signaling pathways - involving 40 genes of optimal relevance - critical for arterial endothelial cell differentiation. CRISPR-Cas9 gene editing technology allowed the creation of reporter cell lines to monitor arterial differentiation in real time.

The investigators reported in the July 10, 2017, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences that by using these protocols they were able to produce endothelial cells from multiple human embryonic and induced pluripotent stem cell lines with gene expression profiles, oxygen consumption rates, nitric oxide production levels, shear stress responses, and TNFalpha-induced leukocyte adhesion rates characteristic of arterial endothelial cells.

"Our ultimate goal is to apply this improved cell derivation process to the formation of functional arteries that can be used in cardiovascular surgery," said senior author Dr. James Thomson, professor of cell and regenerative biology at the Morgridge Institute for Research. "This work provides valuable proof that we can eventually get a reliable source for functional arterial endothelial cells and make arteries that perform and behave like the real thing."

Related Links:
Morgridge Institute for Research


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
Multichem ID-B
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.